Shao‐Chun Wang

8.3k total citations · 2 hit papers
149 papers, 6.1k citations indexed

About

Shao‐Chun Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shao‐Chun Wang has authored 149 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 42 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Shao‐Chun Wang's work include HER2/EGFR in Cancer Research (16 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and MicroRNA in disease regulation (8 papers). Shao‐Chun Wang is often cited by papers focused on HER2/EGFR in Cancer Research (16 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and MicroRNA in disease regulation (8 papers). Shao‐Chun Wang collaborates with scholars based in United States, Taiwan and China. Shao‐Chun Wang's co-authors include Mien‐Chie Hung, Fa‐Kuen Shieh, Kevin C.‐W. Wu, Joseph V. Morabito, Chia‐Kuang Tsung, Lien‐Yang Chou, Peter M. Fischer, Weiya Xia, Pan Hu and Eing‐Mei Tsai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Shao‐Chun Wang

147 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imparting Functionality to Biocatalysts via Embedding Enzymes into Nanoporous Materials by a de Novo Approach: Size-Selective Sheltering of Catalase in Metal–Organic Framework Microcrystals

2015 702 citations Fa‐Kuen Shieh, Shao‐Chun Wang et al. Journal of the American Chemical Society profile →
Advances and prospects of biomarkers for immune checkpoint inhibitors

2024 50 citations Hirohito Yamaguchi, Shao‐Chun Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shao‐Chun Wang United States	39	3.1k	1.6k	896	812	772	149	6.1k
Qin Wang China	40	2.3k 0.7×	706 0.4×	730 0.8×	593 0.7×	372 0.5×	288	6.7k
Jiao Wang China	46	3.4k 1.1×	1.1k 0.7×	1.4k 1.5×	836 1.0×	273 0.4×	245	7.7k
Qing Miao China	45	2.9k 0.9×	611 0.4×	831 0.9×	854 1.1×	447 0.6×	203	6.5k
Zhenzhen Li China	44	3.7k 1.2×	610 0.4×	762 0.9×	876 1.1×	304 0.4×	312	6.8k
Jiyong Liu China	47	2.0k 0.6×	540 0.3×	1.3k 1.5×	406 0.5×	468 0.6×	273	6.9k
Jie Tang China	41	1.5k 0.5×	815 0.5×	448 0.5×	491 0.6×	221 0.3×	229	5.8k
Yan Zhang China	49	3.7k 1.2×	840 0.5×	1.9k 2.1×	600 0.7×	381 0.5×	281	8.6k
Hang Zhang China	40	2.9k 0.9×	1.2k 0.7×	464 0.5×	856 1.1×	166 0.2×	228	5.9k
David Stirling United Kingdom	47	5.3k 1.7×	2.7k 1.7×	441 0.5×	313 0.4×	400 0.5×	109	10.1k
Christopher R. Chitambar United States	36	1.5k 0.5×	1.3k 0.8×	359 0.4×	431 0.5×	244 0.3×	117	4.5k

Countries citing papers authored by Shao‐Chun Wang

Since Specialization

Citations

This map shows the geographic impact of Shao‐Chun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Chun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Chun Wang more than expected).

Fields of papers citing papers by Shao‐Chun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao‐Chun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Chun Wang. The network helps show where Shao‐Chun Wang may publish in the future.

Co-authorship network of co-authors of Shao‐Chun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shao‐Chun Wang. A scholar is included among the top collaborators of Shao‐Chun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao‐Chun Wang. Shao‐Chun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Wenhao, Peng Ye, Hao‐Ching Wang, et al.. (2025). Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8⁺ T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1. Advanced Science. 12(13). e2404961–e2404961. 1 indexed citations

Chen, Hsiao‐Fan, Wei‐Jan Wang, Chung‐Yu Chen, et al.. (2023). The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2. eLife. 12. 14 indexed citations

Yamaguchi, Hirohito, Shao‐Chun Wang, & Mien‐Chie Hung. (2022). Prospects of the potential strategies to improve the efficacy of anti‐PD‐1/PD‐L1 therapy. Clinical and Translational Medicine. 12(5). e803–e803. 5 indexed citations

Wang, Shao‐Chun, et al.. (2022). A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma. Cells. 11(15). 2399–2399. 11 indexed citations

Liu, Wei, Shao‐Chun Wang, Qian Sun, et al.. (2022). Experimental study on thermochemical composite system huff-n-puff process in ultra-heavy oil production. Fuel. 332. 126014–126014. 21 indexed citations

Wang, Shao‐Chun, et al.. (2022). Circ_0006220 promotes non-small cell lung cancer progression via sponging miR-203-3p and regulating RGS17 expression. Human & Experimental Toxicology. 41. 3510081094–3510081094. 3 indexed citations

Hu, Junli, et al.. (2021). Bedside echocardiography for diagnosis of intracardiac cement embolism after percutaneous vertebroplasty: A case report. Journal of Cardiac Surgery. 36(10). 3929–3932. 1 indexed citations

Huang, Sheng‐Teng, Yeh Chen, Wei‐Chao Chang, et al.. (2021). Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Viruses. 13(5). 826–826. 24 indexed citations

Wang, Shao‐Chun, Yeh Chen, Yuchuan Wang, et al.. (2020). Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease. American Journal of Cancer Research. 10(12). 4538–4546. 66 indexed citations

10.

Fan, Chi‐Chen, Chen‐Yuan Lin, Ling‐Chu Chang, et al.. (2020). EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. Redox Biology. 34. 101571–101571. 42 indexed citations

11.

Liu, Liang‐Chih, et al.. (2019). Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2/HER2 positivity in breast cancer. The Breast. 46. 64–69. 57 indexed citations

12.

Wang, Yuanliang, et al.. (2019). The exosomal compartment protects epidermal growth factor receptor from small molecule inhibitors. Biochemical and Biophysical Research Communications. 510(1). 42–47. 10 indexed citations

13.

Zhou, Yingjie, et al.. (2017). Effects of simple posterior decompression and fusion fixation as treatment strategy for complete thoracic fracture dislocation. Zhonghua chuangshang zazhi. 33(10). 890–895. 1 indexed citations

14.

Lo, Wei‐Shang, Yu‐Shen Hsu, Shao‐Chun Wang, et al.. (2017). Shielding against Unfolding by Embedding Enzymes in Metal–Organic Frameworks via a de Novo Approach. Journal of the American Chemical Society. 139(19). 6530–6533. 333 indexed citations

15.

Cui, Jiajun, Tianying Wu, Jiang Wang, et al.. (2012). Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells. Cancer Research. 72(21). 5625–5634. 88 indexed citations

16.

Zhao, Huajun, Yuan-Hung Lo, Li Ma, et al.. (2011). Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth. Molecular Cancer Therapeutics. 10(1). 29–36. 76 indexed citations

17.

Lo, Yuan‐Hung, et al.. (2011). Inhibition of c-ABL sensitizes breast cancer cells to the dual ErbB receptor tyrosine kinase inhibitor lapatinib (GW572016).. PubMed. 31(3). 789–95. 16 indexed citations

18.

Ge, Junbo, Aijun Sun, Vesa Paajanen, et al.. (2008). Molecular and Clinical Characterization of a Novel SCN5A Mutation Associated With Atrioventricular Block and Dilated Cardiomyopathy. Circulation Arrhythmia and Electrophysiology. 1(2). 83–92. 65 indexed citations

19.

Wang, Shao‐Chun, Huang‐Chun Lien, Weiya Xia, et al.. (2004). Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell. 6(3). 251–261. 241 indexed citations

20.

Asada, Shinichi, Yongmun Choi, Masaki Yamada, et al.. (2002). External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. Proceedings of the National Academy of Sciences. 99(20). 12747–12752. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact